参考文献: [1] Verma V, McMillan MT, Grover S, Simone CB 2nd. Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017;97(1):146-154. doi:10.1016/j.ijrobp.2016.09...
三、2024 Version 3 版本在 2024 Version 2 版本的基础上做了如下调整: NSCL-18 ►新增脚注 II:FDA 批准的生物类似物是合适的替代选择。 参考文献 [1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Non-Small Cell Lung Cancer, Version 3.2024, March 12, 2024. 作者:黄玉庭;编辑...
NSCL-J 6-6 ►新增参考文献 40:Solomon BJ, Drilon A, Lin JJ, et al. Repotrectinib in patients with NTRK fusion-positive advanced solid tumors, including non-small cell lung cancer: update from the phase 1/2 TRIDENT-1 trial. Ann Oncol. 2023;34:S787-S788. 知识拓展 根据TRIDENT-1Ⅰ...
[2]Oshima,Y.,Tanimoto,T.,Yuji,K.,&Tojo,A.(2018).EGFR-TKI-associated interstitial pneumonitis in nivolumab-treated patients with non-small cell lung cancer.JAMA Oncology,4(8),1112–1115.https://doi.org/10.1001/jamaoncol.2017.4526 [3]Shih J-Y,et al.Amivantamab plus chemotherapy vs chemoth...
肺癌是全球癌症相关死亡的主要原因,尤其是非小细胞肺癌(non-small cell lung cancer,NSCLC).随着低剂量螺旋CT普及和人们体检意识提高,肺结节检出人数增多,对规范化的诊疗指南需求更大.2024年4月23日,美国国家综合癌症网络发布第5版NSCLC临床实践指南.与2023年第5版指南相比,2024年第5版更新内容主要集中于诊断评估,围...
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomar...
[2] Solomon BJ,Drilon A,Lin JJ,et al.Repotrectinib in patients with NTRK fusion-positive advanced solid tumors,including non-small cell lung cancer:Update from the phase 1/2 TRIDENT-1 trial[abstract].Ann Oncol 2023;34:Abstract 1372P. ...
靶向治疗及免疫治疗在非小细胞肺癌(non-small cell lung cancer,NSCLC)的治疗中发挥了重要的作用,分子分型是NSCLC实施治疗的前提。检测的标准化可提升检测结果的准确性,使患者更大程度上获益。随着分子检测技术的发展和肿瘤相关通路研究的深入,越来越多的与NSCLC治疗相关的基因及位点被发现。
[1]中国抗癌协会肺癌专业委员会, 中华医学会肿瘤学分会肺癌学组, 中国胸部肿瘤研究协作组. Ⅰ~ⅢB期非小细胞肺癌完全切除术后辅助治疗指南(2021版)[J].中华医学杂志, 2021, 101(16):1132-1142. [2]NCCN Clinical Practice Guidelines in Oncology:Non–Small Cell Lung Cancer, Version 7.2024....
Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal...